JSP Pharmaceutical Manufacturing (Thailand) Public Balance Sheet Health
Financial Health criteria checks 6/6
JSP Pharmaceutical Manufacturing (Thailand) Public has a total shareholder equity of THB958.9M and total debt of THB160.8M, which brings its debt-to-equity ratio to 16.8%. Its total assets and total liabilities are THB1.4B and THB484.8M respectively. JSP Pharmaceutical Manufacturing (Thailand) Public's EBIT is THB81.1M making its interest coverage ratio 4.9. It has cash and short-term investments of THB49.1M.
Key information
16.8%
Debt to equity ratio
฿160.79m
Debt
| Interest coverage ratio | 4.9x |
| Cash | ฿49.14m |
| Equity | ฿958.85m |
| Total liabilities | ฿484.78m |
| Total assets | ฿1.44b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: JSP's short term assets (THB328.7M) exceed its short term liabilities (THB252.4M).
Long Term Liabilities: JSP's short term assets (THB328.7M) exceed its long term liabilities (THB232.4M).
Debt to Equity History and Analysis
Debt Level: JSP's net debt to equity ratio (11.6%) is considered satisfactory.
Reducing Debt: JSP's debt to equity ratio has reduced from 134.8% to 16.8% over the past 5 years.
Debt Coverage: JSP's debt is well covered by operating cash flow (73.6%).
Interest Coverage: JSP's interest payments on its debt are well covered by EBIT (4.9x coverage).